Decreased plasma membrane fluidity of peripheral blood lymphocytes after diethyldithiocarbamate (DTC) therapy in HIV-infected patients.
Details
Serval ID
serval:BIB_2CD6545E68BA
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Decreased plasma membrane fluidity of peripheral blood lymphocytes after diethyldithiocarbamate (DTC) therapy in HIV-infected patients.
Journal
European Journal of Clinical Pharmacology
ISSN
0031-6970 (Print)
ISSN-L
0031-6970
Publication state
Published
Issued date
1989
Volume
37
Number
5
Pages
521-523
Language
english
Abstract
In seeking the putative mechanism of action of diethyldithiocarbamate (DTC) on the immune status of HIV infected patients, the plasma membrane fluidity of peripheral blood lymphocytes (PBL) from DTC-treated and untreated patients (CDC III-IVc1) was determined. Anisotropy values of the fluorescent probe 6-(9-anthroyloxy) stearic acid were increased in DTC-treated patients (0.175 vs 0.161), indicating decreased PBL plasma membrane fluidity. The membrane rigidifying effect was significantly greater 4 h after i.v. drug administration (0.185 in treated patients). As the membrane fluidity and the function of membrane embedded antigen are interdependent, it is possible that alterations in biophysical and/or biochemical properties of membranes may account for the beneficial effect of DTC on the immune function and clinical status of HIV infected patients.
Keywords
Acquired Immunodeficiency Syndrome/blood, Acquired Immunodeficiency Syndrome/drug therapy, Cell Membrane/drug effects, Diphenylhexatriene/diagnostic use, Ditiocarb/adverse effects, Ditiocarb/therapeutic use, Fluorescent Dyes, Humans, Lymphocytes/drug effects, Membrane Fluidity/drug effects, Spectrometry, Fluorescence, Stearic Acids/diagnostic use
Pubmed
Create date
25/11/2011 18:37
Last modification date
20/08/2019 13:11
Usage data
